FindTrial
Sign In

Infection by resistant organisms & their Genes in Post Covid Era- An Observational Study in ICU

Epidemiological study of Infection by resistant organisms & their Gene expression in Post Covid Era- An Observational Study in a tertiary center ICU - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085773
Enrollment
50
Registered
2025-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A499- Bacterial infection, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Bhawesh Upreti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients whose samples were sent for multiplex PCR for Syndromic testing during study period.

Exclusion criteria

Exclusion criteria: Patients 90 years of age.

Design outcomes

Primary

MeasureTime frame
To record the organisms identified in samples of ICU patients using multiplex PCR along with the resistance genes expressed by themTimepoint: At Baseline (On admission)—

Secondary

MeasureTime frame
Prevalence of carbapenem resistance genesTimepoint: At Baseline (On admission);Antibiotics used in those infected with carbapenem resistant organismsTimepoint: At Baseline (On admission);30 days Mortality among those with carbapenem resistanceTimepoint: At Baseline (On admission);Prevalence of multi colonizationTimepoint: At Baseline (On admission);Comparison with ICU infections by carbapenem resistant organisms in pre COVID eraTimepoint: At Baseline (On admission)—

Countries

India

Contacts

Public ContactBhawesh Upreti

Indira Gandhi Institute of Medical Sciences Patna

bhaweshupreti802@gmail.com9756114748

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026